NCT00825019View on ClinicalTrials.gov

Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and Paroxetine

PHASE3CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

December 31, 2004

Conditions
Major Depressive Disorders
Interventions
DRUG

amibegron (SR58611A)

oral administration of 2x 700 mg/day in 12h intervals

DRUG

placebo

oral administration in 12h intervals

DRUG

paroxetine

oral administration of 20 mg/day

Trial Locations (1)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY